Literature DB >> 27630861

No Benefit of BCR-ABL1 Screening in Polycythemia.

Stephen E Langabeer1.   

Abstract

Entities:  

Keywords:  Chronic myeloid leukemia; Erythrocytosis; Molecular diagnostics

Year:  2016        PMID： 27630861      PMCID： PMC5020178          DOI： 10.7860/JCDR/2016/20228.8176

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN： 0973-709X


× No keyword cloud information.
  4 in total

1.  Isolated polyglobulia as an uncommon presentation of chronic myeloid leukaemia.

Authors:  Claudio Fozza; Silvana Bonfigli; Francesco Longu; Simonetta Pardini; Fausto Dore
Journal:  Blood Cells Mol Dis       Date:  2015-10-28       Impact factor: 3.039

Review 2.  The diagnosis and management of erythrocytosis.

Authors:  Clodagh Keohane; Mary Frances McMullin; Claire Harrison
Journal:  BMJ       Date:  2013-11-18

3.  Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib.

Authors:  A Zhou; E M Knoche; E K Engle; D A C Fisher; S T Oh
Journal:  Blood Cancer J       Date:  2015-10-02       Impact factor: 11.037

Review 4.  Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.